About Isolation Sciences LLC
Isolation Sciences formed in 2006, when Dr. Charles Akers, a research scientist, developed a vision: to address the problems of rapid and continuous access to the field of containment.
After years of development, the partners launched the Continuous Access Port product at LABS21 2009 conference in New Orleans. Isolation Sciences began calling on architects, EHS and energy specifiers.
With great interest from the market place, the first orders were for some academic, pharmaceutical and governmental medical research facilities. It was apparent that their fume hoods were missing this product's features: a physical barrier that lowered the amount of conditioned air required to be exhausted to meet safety standards, to conserve energy, and to lower risk to accidental exposure to fume hood vapors, spills, splashing and energetic events.
With ever increasing numbers of installations across the United States, Isolation Sciences is committed to changing the way we think about fume hood operations for a greener and safer laboratory.
Meet our Isolation Sciences Team
 Charles Akers
CEO and Business Development
Dr. Akers co-invented the Continuous Access Port technology in 2006, with the inspiration: If one could have movable ports in a physical flexible barrier film, one could have unobstructed access to the interior of an isolated or containment space. The initial concept application was a temporary individual patient isolation enclosure that would allow medical personnel full unobstructed, rapid and continuous access to the isolated patient and maintain full medical isolation capability. In 2008, Chuck was asked to apply the Continuous Access Port technology to fume hood operations to lower excessive energy loss and improve fume hood containment features. As a laboratory scientist doing research and development, Chuck has firsthand experience with the dangers of poor fume hood containment and high energy loss. Utilizing the current CAP design and future technologies, Chuck hopes to lower the need to condition laboratory air that is currently being exhausted through fume hoods to meet OSHA and ANSI standards and improve the containment capability of fume hoods to lower laboratory exposure toxic contaminates.
 Ted Arts
Director of Product Development
and Manufacturing
Leading Isolation Sciences’ product development strategy, Mr. Arts relies on his recent effort at generating air handling and filtration devices for emergency medical isolation and containment from individuals to mass casualty medical surge pandemic events. Ted has nearly thirty years experience in technical innovation, product development, manufacturing and distribution of air handling/filtration in several market segments. Mr. Art’s professional career includes developing the United States as a new market for a Canadian manufacturer of air conditioning equipment resulting in capturing 50% United States market share within a five‐year period. In 1998, Mr. Arts founded Isolation Systems Inc., where he developed and patented new concepts in isolation and control to ‘Capture, Contain and Neutralization’ airborne infectious agents. Leading Continuous Access Port engineering and production activities, he continues to develop innovative concepts that transitioned to unique and practical market solutions for infection control, air safety, and energy conservation applications.
|
